U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Naltrexone

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

Year introduced: 1986 (1976)

PubMed search builder options

Subheadings:

Tree Number(s): D03.132.577.249.706.550, D03.605.497.750.550, D03.633.400.686.750.550, D04.615.723.795.706.550

MeSH Unique ID: D009271

Registry Number: 5S6W795CQM

Entry Terms:

  • Trexan
  • EN-1639A
  • EN1639A
  • EN 1639A
  • Antaxone
  • Celupan
  • ReVia
  • Nalorex
  • Nemexin
  • Naltrexone Hydrochloride

Previous Indexing:

Pharmacologic Action:

Supplemental Content

Loading ...